Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Use of CIP Systems in Cleaning Lyophilizers – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Use of CIP Systems in Cleaning Lyophilizers – V 2.0

Standard Operating Procedure for Use of CIP Systems in Cleaning Lyophilizers


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/157/2025
Supersedes SOP/SIM/157/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This Standard Operating Procedure (SOP) describes the procedure for effective and validated use of Clean-In-Place (CIP) systems for cleaning lyophilizers used in sterile injectable manufacturing. The purpose is to ensure removal of product

residues, microbial load, and contaminants in accordance with GMP, WHO, and ICH guidelines.

2. Scope

This SOP applies to all lyophilizers installed in sterile injectable manufacturing areas that are equipped with CIP functionality. It includes procedures for cleaning initiation, system checks, chemical cycles, post-cleaning verification, documentation, and release for reuse.

3. Responsibilities

  • Production Operator: Responsible for initiating, monitoring, and recording the CIP cycle as per SOP.
  • Maintenance Engineer: Responsible for ensuring the CIP system is functioning correctly and for any troubleshooting.
  • QA Officer: Responsible for verifying cleaning effectiveness, reviewing documentation, and approving equipment for next use.
  • QC Analyst: Responsible for conducting TOC and microbial swab testing post-cleaning, if applicable.
See also  Manufacturing: SOP for Conducting Microbial Monitoring during Filling Process - V 2.0

4. Accountability

The Head of Production and Head of Quality Assurance are accountable for ensuring adherence to this SOP and compliance with GMP requirements.

5. Procedure

5.1 Pre-Cleaning Checks

  1. Ensure the lyophilizer is not under vacuum and the previous product batch is completely removed.
  2. Check for visible residue and remove bulk particles manually using lint-free wipes and WFI.
  3. Ensure the lyophilizer doors and ports are securely closed and sealed.
  4. Verify availability of validated cleaning agents such as sodium hydroxide 0.5%, nitric acid 0.5%, and sterile WFI.
  5. Ensure the temperature, flow rate, and pressure sensors in the CIP system are calibrated.
  6. Affix “Under Cleaning” status label near the lyophilizer control panel.

5.2 CIP System Operation

  1. Access the CIP system interface via the HMI (Human Machine Interface) panel.
  2. Select the appropriate validated CIP cycle based on the product cleaned previously.
  3. Start the automated cleaning sequence which includes the following stages:
    • Pre-Rinse with WFI at 60–70°C for 10 minutes
    • Alkaline Wash with 0.5% NaOH at 75°C for 15 minutes
    • Intermediate Rinse with WFI until pH reaches below 9
    • Acid Rinse with 0.5% Nitric Acid for 10 minutes at ambient temperature
    • Final Rinse with WFI until conductivity is below 1.3 µS/cm
  4. Monitor and document parameters such as cycle time, temperature, flow rate, and pH during each stage in Annexure-1.
See also  Manufacturing Operations: SOP for Prefilled Syringe Assembly Line Operations - V 2.0

5.3 Cleaning Validation and Verification

  1. Upon completion of the CIP cycle, open the lyophilizer and inspect all surfaces for cleanliness.
  2. Collect rinse water samples and submit for TOC analysis and conductivity testing.
  3. If applicable, perform microbial swab testing of internal surfaces using sterile swabs and submit for bioburden testing.
  4. All test results must comply with established acceptance criteria:
    • TOC < 500 ppb
    • Conductivity < 1.3 µS/cm
    • Microbial Count < 10 CFU/100 cm²
  5. Record and attach laboratory test reports in Annexure-2.

5.4 Post-Cleaning Activities

  1. Remove all cleaning labels after QA approval.
  2. Re-connect any accessories or ports removed during preparation.
  3. Ensure the lyophilizer is placed in ‘Ready for Use’ status in the equipment logbook and BMR.
  4. Update the cleaning status in the equipment cleaning schedule.

5.5 Special Considerations

  • Repeat CIP cycle if test results exceed acceptance criteria.
  • In case of manual intervention, document reasons and corrective actions taken.
  • Do not operate lyophilizer without QA clearance post-CIP.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • CIP: Clean-In-Place
  • HMI: Human Machine Interface
  • TOC: Total Organic Carbon
  • WFI: Water for Injection
  • CFU: Colony Forming Units
  • BMR: Batch Manufacturing Record
See also  Sterile Injectable Manufacturing: SOP for Handling Out-of-Trend (OOT) Results in Manufacturing - V 2.0

7. Documents

  1. Annexure-1: CIP Execution and Parameter Log
  2. Annexure-2: Laboratory Cleaning Test Results
  3. Annexure-3: Cleaning Checklist and QA Release

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • WHO Technical Report Series No. 937 Annex 4
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: CIP Execution and Parameter Log

Date Lyophilizer ID Cycle Type Temp (°C) Flow (L/min) Time (min) Operator
23/06/2025 LYO-02 Full Cycle 75 50 60 Ajay Rao

Annexure-2: Laboratory Cleaning Test Results

Sample ID TOC (ppb) Conductivity (µS/cm) Microbial Count (CFU) Status Analyst
RIN-157 115 1.2 2 Pass Ritika Sharma

Annexure-3: Cleaning Checklist and QA Release

Item Checked (Y/N) Comments QA Verified By
All visible residue removed Y Clean Sunita Reddy
All cycle parameters within range Y Validated Sunita Reddy
Lab results attached Y Compliant Sunita Reddy

Revision History:

Revision Date Revision No. Details Reason Approved By
15/03/2022 1.0 Initial SOP Release New Equipment QA Head
24/06/2025 2.0 Cycle parameters and annexures updated Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: How to Set Up a Role-Based SOP Training Matrix
Next Post: Unlogged Cleaning Deviations in Batch Records: A GMP Compliance Risk

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version